Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 8, 2003, Pages 1091-1097

  Doki, Kosuke ^a   Hayakawa, Toru ^a   Lin, Wenhui ^a   Yanaguimoto, Hitomi ^a   Ding, Guohua ^a   Inotsume, Nobuo ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IBUFENAC; IBUPROFEN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHIRALITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EFFECT; DRUG ELIMINATION; DRUG GRANULE; DRUG HALF LIFE; ENANTIOMER; MALE; MEAN RESIDENCE TIME; NONHUMAN; POWDER; RABBIT; RACEMIC MIXTURE; SERUM; SUSTAINED RELEASE FORMULATION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DUODENUM; IBUPROFEN; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; POWDERS; RABBITS; STEREOISOMERISM;

EID: 0042526067     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021404     Document Type: Article

References (27)

1. Adams, S. S., Bresloff, P., Mason, C. G. (1976) Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the (-)-isomer. J. Pharm. Pharmacol. 28: 256-257
2. Aiba, T., Tse, M. M., Lin, E. T., Koizumi, T. (1999) Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers. Biol. Pharm. Bull. 22: 616-622
3. Beck, W. S., Geisslinger, G., Engler, G., Engler, H., Brune, K. (1991) Pharmacokinetics of ibuprofen enantiomers in dogs. Chirality 3: 165-169
4. Berry, B. W., Jamali, F. (1991) Presystemic and systemic chiral inversion of R(-)-fenoprofen in the rat. J. Pharmacol. Exp. Ther. 258: 695-701
5. Caldwell, J., Hutt, A. J., Fournel-Gigleux, S. (1988) The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem. Pharmacol. 37: 105-114
6. Metabolic stereoisomeric inversion of ibuprofen in mammals. (1991) Biochim. Biophys. Acta 1078: 411-417
7. Davies, N. M. (1998) Clinical pharmacokinetics of ibuprofen. The First 30 years. Clin. Pharmacokinet. 34: 101-154
8. Evans, A. M., Nation, R. L., Sansom, L. N., Bochner, F., Somogyi, A. A. (1989) Stereoselective plasma protein binding of ibuprofen enantiomers. Eur. J. Clin. Pharmacol. 36: 283-290
9. Fournel, S., Caldwell, J. (1986) The metabolic chiral inversion of 2-phenylpropionic acid in rat, mouse and rabbit. Biochem. Pharmacol. 35: 4153-4159
10. Geisslinger, G., Stock, K. P., Bach, G. L., Loew, D., Brune, K. (1989) Pharmacological differences differences between R(-)- and S(+)-ibuprofen. Agents Actions 27: 455-457
11. Glowka, F. K. (2000) Stereoselective pharmacokinetics of ibuprofen and its lysinate from suppositories in rabbits. Int. J. Pharm. 199: 159-166
12. Hall, S. D., Rudy, A. C., Knight, P. M., Brater, D. C. (1993) Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans. Clin. Pharmacol. Ther. 53: 393-400
13. Hoult, J. R., Jackson, B. R., Benicka, E., Patel, B. K., Hutt, A. J. (1999) Chromatographic resolution, chiroptical characterization and preliminary pharmacological evaluation of the enantiomers of butibufen: A comparison with ibuprofen. J. Pharm. Pharmacol. 51: 1201-1205
14. Hutt, A. J., Caldwell, J. (1983) The metabolic chiral inversion of 2-arylpropionic acid - A novel route with pharmacological consequences. J. Pharm. Pharmacol. 35: 693-704
15. Jamali, F., Singh, N. N., Pasutto, F. M., Russell, A. S., Coutts, R. T. (1988) Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rats. Pharm. Res. 5: 40-43
16. Jamali, F., Mehvar, R., Russell, A. S., Sattari, S., Yakimets, W., Koo, J. (1992) Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: Intestinal chiral inversion. J. Pharm. Sci. 81: 221-225
17. Jeffrey, P., Tucker, G. T., Bye, A., Crewe, H. K., Wright, P. A. (1991) The site of inversion of R(-)-ibuprofen: Studies using rat in-situ isolated perfused intestine/liver preparations. J. Pharm. Pharmacol. 43: 715-720
18. Lee, E. J., Williams, K., Day, R., Graham, G., Champion, D. (1985) Stereoselective disposition of ibuprofen enantiomers in man. Br. J. Clin. Pharmacol. 19: 669-674
19. Nagashima, H., Tanaka, Y., Watanabe, H., Hayashi, R., Kawada, K. (1984) Optical inversion of (2R)- to (2S)-isomers of 2-[4-(2-Oxocyclopentylmethyl)-phenyl]propionic acid (loxopropen), a new anti-inflammatory agent, and its monohydroxy metabolites in the rat. Chem. Pharm. Bull. (Tokyo) 32: 251-257
20. Perreault, S., Dumont, L., Villiere, V., Ong, H., Adam, A., Du Souich, P. (1993) Hepatic and extrahepatic metabolism of salbutamol in anesthetized rabbits. Drug Metab. Dispos. 21: 485-491
21. Rubin, A., Knadler, M. P., Ho, P. P., Bechtol, L. D., Wolen, R. (1985) Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. J. Pharm. Sci. 74: 82-84
22. Sattari, S., Jamali, F. (1994) Evidence of absorption rate dependency of ibuprofen inversion in the rat. Chirality 6: 435-439
23. Scheuerer, S., Hall, S. D., Williams, K. M., Geisslinger, G. (1998) Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers. Clin. Pharmacol. Ther. 64: 168-176
24. Sekikawa, H., Yagi, N., Oda, K., Kenmotsu, H., Takada, M., Chen, H. F., Lin, E. T., Benet, L. Z. (1995) Biliary excretion of furosemide glucuronide in rabbits. Biol. Pharm. Bull. 18: 447-453
25. Tan, S. C., Patel, B. K., Jackson, S. H. D., Swift, C. G., Hutt, A. J. (2002) Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers. Xenobiotica 32: 683-697
26. Vos, M. R., Mayer, J. M., Etter, J.-C., Testa, B. (1996) Clofibric acid increases the unidirectional chiral inversion of ibuprofen in rat liver preparations. Xenobiotica 26: 571-582
27. Yamaoka, K., Nakagawa, T., Uno, T. (1978) Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6: 547-558